BATS BZX Real-Time Price
As of 11:34am ET
| -0.02 / -2.53%|
The 1 analysts offering 12-month price forecasts for Rexahn Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +354.55% increase from the last price of 0.77.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.